Disruption of th17/treg balance in the sputum of patients with chronic obstructive pulmonary disease

The American Journal of the Medical Sciences
Haijun LiWei Xiao

Abstract

Amplified inflammation persists in the airways of patients with chronic obstructive pulmonary disease (COPD); however, the underlying mechanism is still unclear. Th17/T regulatory cells (Treg) imbalance may exist in the airways and contribute to this abnormal inflammation. This study involved 21 patients with COPD, 21 healthy smokers (HS), and 21 healthy nonsmokers (HNS). We investigated receptor-related orphan receptor (RORC2) and forkhead box P3 (FOXP3) mRNA expression in induced sputum by real-time polymerase chain reaction and assayed IL-17, IL-10, TGF-β and IL-6 by enzyme-linked immunosorbent assay. Th17 and Treg cells in peripheral blood were analyzed by flow cytometry. The level of sputum FOXP3 mRNA in both COPD and HNS was lower than that in HS (PCOPD = 0.017; PHNS = 0.009). In contrast, the level of RORC2 mRNA was markedly higher in COPD than in either HS or HNS (PHS = 0.005; PHNS < 0.001). There was a correspondingly elevated ratio of sputum RORC2 to FOXP3 mRNA in COPD. Concentrations of IL-17, TGF-β and IL-6 were elevated in COPD sputum. In peripheral blood, both Th17 and Treg cells were elevated in COPD. A compartmental imbalance of Th17 over Treg exists in the airways of patients with COPD, suggesting a defect in a...Continue Reading

References

Aug 3, 2001·The Journal of Biological Chemistry·L A SchubertS F Ziegler
Nov 30, 2006·PLoS Medicine·Colin D Mathers, Dejan Loncar
Dec 7, 2007·Seminars in Immunology·Ivaylo I IvanovDan R Littman
Aug 8, 2008·The European Respiratory Journal·S IsajevsA Kratovska
Jan 16, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Wan C TanNan-Shan Zhong
Feb 7, 2009·The European Respiratory Journal·J PlumbS D Singh
May 26, 2009·Immunity·Liang ZhouDan R Littman
Jun 6, 2009·European Journal of Immunology·Derya Unutmaz
Jul 16, 2009·Inflammation & Allergy Drug Targets·Chang H Kim
Aug 28, 2009·The New England Journal of Medicine·Pierre MiossecVijay K Kuchroo
Sep 11, 2009·Proceedings of the American Thoracic Society·Don D Sin, Jørgen Vestbo
Apr 14, 2010·Scandinavian Journal of Immunology·J LiJ Xia
Mar 11, 2011·Journal of Immunotherapy·Jamie S MaderRobert C Bleackley
Jun 10, 2011·Respiratory Research·Ester Roos-EngstrandAnders Blomberg
Jul 19, 2011·Respiratory Medicine·María Inés Vargas-RojasRaúl H Sansores
Oct 10, 2012·International Immunopharmacology·Huaying WangWanjun Yu

❮ Previous
Next ❯

Citations

Jan 26, 2016·Pulmonary Pharmacology & Therapeutics·Zhilong Jiang, Lei Zhu
Feb 20, 2016·Journal of Receptor and Signal Transduction Research·Saber ImaniYunes Panahi
May 15, 2016·Seminars in Immunopathology·Gaetano CaramoriIan Adcock
Oct 11, 2017·Expert Review of Clinical Immunology·Maryam ImanJafar Salimian
Jul 2, 2017·Journal of Cellular Physiology·Yunes PanahiAmirhossein Sahebkar
Jan 11, 2019·PloS One·Juliana Tiyaki ItoFernanda Degobbi Tenorio Quirino Dos Santos Lopes
Oct 14, 2017·The European Respiratory Journal·Olivier Le RouzicPhilippe Gosset
Jul 27, 2017·Expert Review of Respiratory Medicine·Mathew Suji EapenSukhwinder Singh Sohal
Nov 26, 2015·Current Opinion in Allergy and Clinical Immunology·Lorenzo CosmiFrancesco Annunziato
Jul 2, 2020·International Journal of Chronic Obstructive Pulmonary Disease·Karolina SidletskayaYulia Denisenko

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here